Home/ Supplements/ Glucosamine/ ImmunoMod-A

ImmunoMod-A

product on market Capsule Designs for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Curcumin C3 Complex and PARACTIN provide moderate evidence for supporting immune function and inflammatory response. N-Acetyl Glucosamine is utilized for joint and mucosal health, though evidence for systemic immune modulation is more limited. The formulation maintains a high safety profile based on available data.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for ImmunoMod-A
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 450.0mg (254 products) 243 studies (A:0, B:100)
Market median: 1000.0mg (1115 products) 24 studies (A:0, B:9)
PARACTIN(R)
250 mg

Other Ingredients

Microcrystalline Cellulose Vegetable Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take 4 capsules per day with meals, or as directed by your health care practitioner.

Formulation Notes

Does not contain gluten.

Additional Information

Guaranteed GMP COMPLIANT Products

Manufactured in a GMP Audited Facility in Arlee, MT, USA

STORE IN A COOL, DRY PLACE.

Notice: Color, size or shape may appear different between lots.

For Professional Use Only

IMM120

MADE WITH NON-GMO INGREDIENTS

Metadata

Product Details

UPC / SKU8 79452 00397 2
DSLD Entry Date2014-04-25
Product TypeOther Combinations
FormCapsule
DSLD ID32003
Data Updated2026-04-11
Research

Research Evidence

39
Research Sources
50
Avg Quality
20
Rct
9
Meta Analysis
4
Clinical Trial
3
Systematic Review
1
Regulatory Source
1
Openfda Safety
B Interventions for the management of temporomandibular joint osteoarthritis
Systematic Review The Cochrane database of systematic reviews 2012 PubMed DOI
B Glucosamine therapy for treating osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2005 PubMed
B Chondroitin for osteoarthritis
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis
Meta Analysis Archives of orthopaedic and trauma surgery 2023 PubMed DOI
B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Rct The New England journal of medicine 2006 PubMed
B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review
Systematic Review International journal of molecular sciences 2023 PubMed DOI
B Scientific Opinion on glucosamine and joint health
Regulatory Source EFSA Journal 2009 DOI
B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis
Meta Analysis Computational and mathematical methods in medicine 2022 PubMed DOI
B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
Rct Annals of the rheumatic diseases 2016 PubMed DOI
B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials
Meta Analysis Journal of orthopaedic surgery and research 2018 PubMed DOI
View all evidence for Glucosamine →
Compare

Similar Products

View all Glucosamine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.